<?xml version="1.0" ?>
<document id="3e86a490327b0f473d776363d3f2e67ddd04d681">
  <chunk id="3e86a490327b0f473d776363d3f2e67ddd04d681.c0" text="Human Kinase/Phosphatase-Wide RNAi Screening Identified Checkpoint Kinase 2 as a Cellular Factor Facilitating Japanese Encephalitis Virus Infection">
    <entity charOffset="110-131" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c0.e0" ontology_id="DOID_10844" text="Japanese Encephalitis" type="disease"/>
    <entity charOffset="119-131" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c0.e1" ontology_id="DOID_9588" text="Encephalitis" type="disease"/>
    <entity charOffset="132-147" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c0.e2" ontology_id="DOID_934" text="Virus Infection" type="disease"/>
  </chunk>
  <chunk id="3e86a490327b0f473d776363d3f2e67ddd04d681.c1" text="Japanese encephalitis virus (JEV), a mosquito-borne flavivirus, causes acute encephalitis in humans with high mortality. Not much is known about the interactions between viral and cellular factors that regulate JEV infection. By using a kinase/phosphatase-wide RNAi screening approach, we identified a cell cycle-regulating molecule, checkpoint kinase 2 (CHK2), that plays a role in regulating JEV replication. JEV infection induced G1 arrest and activated CHK2. Inactivation of CHK2 and its upstream ataxia-telangiectasia mutated kinase in JEV-infected cells by using inhibitors reduced virus replication. Likewise, JEV replication was significantly decreased by knockdown of CHK2 expression with shRNA-producing lentiviral transduction. We identified CHK2 as a cellular factor participating in JEV replication, for a new strategy in addressing JEV infection.">
    <entity charOffset="0-21" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e0" ontology_id="DOID_10844" text="Japanese encephalitis" type="disease"/>
    <entity charOffset="9-21" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e1" ontology_id="DOID_9588" text="encephalitis" type="disease"/>
    <entity charOffset="77-89" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e2" ontology_id="DOID_9588" text="encephalitis" type="disease"/>
    <entity charOffset="375-379" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e3" ontology_id="CHEBI_50906" text="role" type="chemical"/>
    <entity charOffset="569-579" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e4" ontology_id="CHEBI_35222" text="inhibitors" type="chemical"/>
    <pair e1="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e0" e2="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e3" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.p0" relation="true"/>
    <pair e1="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e0" e2="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e4" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.p1" relation="true"/>
    <pair e1="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e1" e2="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e3" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.p2" relation="true"/>
    <pair e1="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e1" e2="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e4" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.p3" relation="true"/>
    <pair e1="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e2" e2="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e3" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.p4" relation="true"/>
    <pair e1="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e2" e2="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.e4" id="3e86a490327b0f473d776363d3f2e67ddd04d681.c1.p5" relation="true"/>
  </chunk>
</document>
